Global Licensing & Business Development in the Drug Development Arena

Date: 04/09/2014
Time: 4:30 pm – 5:30 pm
Location: 111 Snell Library
Speaker: Lori Badura, Ph.D., Director, Search and Evaluation, EMD Serono

An overview of the drug development process and the ways in which business development professionals facilitate new product development through acquisitions, collaborations, alliances, and outsourcing. The content will include information about due diligence procedures, as well as commercial and market valuation assessments, for driving intelligence business decisions. The importance of well-applied business development principles will be illustrated through examples of recent high profile deals in the pharma/biotech industry.

Dr. Badura has a global reputation as a leader of Translational Medicine initiatives across numerous therapeutic areas, with expertise in neuroimaging, genomic, and proteomic platform biomarkers. She spent the early part of her career in academia specializing in reproductive neuroendocrinology. She subsequently moved to Pfizer, where she held positions in both discovery and clinical development functions from 2001-2011. She was instrumental in launching Translational Medicine as a discipline at Pfizer, and served as Head of the Translational Medicine line within the Neuroscience Research Unit from 2009-2011. Since 2011, she has pursued career opportunities in Business Development functions, and currently serves as the Director of Search and Evaluation for Neurology at EMD Serono. In this role, she identifies high value assets with potential for addressing significant areas of unmet medical need, with special emphasis on neurological disorders.